The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
iNUDGE: Integration of liquid biopsy based next generation gene sequencing in newly diagnosed NSCLC—A stepped wedge cluster randomized clinical trial.
 
Anthony O. Martella
No Relationships to Disclose
 
Dylan G. Scholes
Stock and Other Ownership Interests - Qiagen NV (QGEN)
 
E. Paul Wileyto
No Relationships to Disclose
 
Ann Tierney
No Relationships to Disclose
 
Meagan Hume
No Relationships to Disclose
 
Megan Roy
Speakers' Bureau - AstraZeneca
 
Shayma Master Kazmi
No Relationships to Disclose
 
Christopher D'Avella
No Relationships to Disclose
 
Samuel J. Kerr
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb/Sanofi (Inst); Genentech (Inst); Merck (Inst)
 
Ramy Sedhom
No Relationships to Disclose
 
Peter Edward Gabriel
Honoraria - National Comprehensive Cancer Network
Travel, Accommodations, Expenses - National Comprehensive Cancer Network
 
Katharine A. Rendle
Honoraria - MJH Healthcare Holdings, LLC
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca; Pfizer (Inst)
Travel, Accommodations, Expenses - MJH Healthcare Holdings, LLC
 
Justin E. Bekelman
Stock and Other Ownership Interests - Reimagine Care
Honoraria - National Comprehensive Cancer Network
Consulting or Advisory Role - AstraZeneca; Healthcare Foundry; Reimagine Care; UnitedHealthcare
Research Funding - Gilead Sciences (Inst); Loxo@Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending: Machine Learning Systems Using Electronic Health Record Data and Patient-Reported Outcomes; 17/972,105
 
Abigail Doucette
No Relationships to Disclose
 
Leland Boisseau
No Relationships to Disclose
 
Melina Elpi Marmarelis
Stock and Other Ownership Interests - Johnson & Johnson; Merck
Honoraria - AstraZeneca; Blueprint Medicines; Janssen Oncology; Novocure; Takeda; Thermo Fisher Scientific
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bristol-Myers Squibb/Celgene; Ikena Oncology; Janssen Oncology; Regeneron
Research Funding - AstraZeneca (Inst); Genentech (Inst); Ikena Oncology (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Regeneron
 
Charu Aggarwal
Consulting or Advisory Role - Abbvie; Arcus Biosciences; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Lilly; Merck; Mirati Therapeutics; Novocure; Pfizer; Sanofi/Regeneron; Takeda
Speakers' Bureau - AstraZeneca (I); Roche/Genentech (I)
Research Funding - AstraZeneca/MedImmune (Inst); Candel Therapeutics (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Loxo@Lilly (Inst); Merck Sharp & Dohme (Inst)